A Research Agenda for Malaria Eradication: Vector Control
Different challenges are presented by the variety of malaria transmission environments present in the world today. In each setting, improved control for reduction of morbidity is a necessary first step towards the long-range goal of malaria eradication and a priority for regions where the disease burden is high. For many geographic areas where transmission rates are low to moderate, sustained and well-managed application of currently available tools may be sufficient to achieve local elimination. The research needs for these areas will be to sustain and perhaps improve the effectiveness of currently available tools. For other low-to-moderate transmission regions, notably areas where the vectors exhibit behaviours such as outdoor feeding and resting that are not well targeted by current strategies, new interventions that target predictable features of the biology/ecologies of the local vectors will be required. To achieve elimination in areas where high levels of transmission are sustained by very efficient vector species, radically new interventions that significantly reduce the vectorial capacity of wild populations will be needed. Ideally, such interventions should be implemented with a one-time application with a long-lasting impact, such as genetic modification of the vectorial capacity of the wild vector population.
Vyšlo v časopise:
A Research Agenda for Malaria Eradication: Vector Control. PLoS Med 8(1): e32767. doi:10.1371/journal.pmed.1000401
Kategorie:
Review
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000401
Souhrn
Different challenges are presented by the variety of malaria transmission environments present in the world today. In each setting, improved control for reduction of morbidity is a necessary first step towards the long-range goal of malaria eradication and a priority for regions where the disease burden is high. For many geographic areas where transmission rates are low to moderate, sustained and well-managed application of currently available tools may be sufficient to achieve local elimination. The research needs for these areas will be to sustain and perhaps improve the effectiveness of currently available tools. For other low-to-moderate transmission regions, notably areas where the vectors exhibit behaviours such as outdoor feeding and resting that are not well targeted by current strategies, new interventions that target predictable features of the biology/ecologies of the local vectors will be required. To achieve elimination in areas where high levels of transmission are sustained by very efficient vector species, radically new interventions that significantly reduce the vectorial capacity of wild populations will be needed. Ideally, such interventions should be implemented with a one-time application with a long-lasting impact, such as genetic modification of the vectorial capacity of the wild vector population.
Zdroje
1. EnayatiA
HemingwayJ
2010 Malaria management: Past, present, and future. Ann Rev Entomol 55 569 591
2. HaySI
RogersDJ
ToomerJF
SnowRW
2000 Annual Plasmodium falciparum entomological inoculation rates [EIR] across Africa: Literature survey, internet access and review. Trans R Soc Trop Med Hyg 94 113 127
3. Kelly-HopeLA
McKenzieFE
2009 The multiplicity of malaria transmission: A review of entomological inoculation rate measurements and methods across sub-Sahan Africa. Malar J 8 19
4. ShaukatAM
BremanJG
McKenzieFE
2010 Using the entomological inoculation rate to assess the impact of vector control on malaria parasite transmission and elimination. Malar J 9 122
5. RansonH
AbdallahH
BadoloA
GuelbeogoWM
Kerah-HinzoumbéC
2009 Insecticide resistance in Anopheles gambiae: Data from the first year of a multi-country study highlight the extent of the problem. Malar J 8 299
6. TereniusO
MarinottiO
SieglaffD
JamesAA
2008 Molecular genetic manipulation of vector mosquitoes. Cell Host Microbe 13 417 423
7. SinkinsSP
GouldF
2006 Gene drive systems for insect disease vectors. Nat Rev Genet 7 427 435
8. The malERA Consultative Group on Monitoring, Evaluation, and Surveillance 2011 A research agenda for malaria eradication: Monitoring, evaluation, and surveillance. PLoS Med 8 e1000400 doi:10.1371/journal.pmed.1000400
9. The malERA Consultative Group on Modeling 2011 A research agenda for malaria eradication: Modeling. PLoS Med 8 e1000403 doi:10.1371/journal.pmed.1000403
10. PampanaEA
1969 A textbook of malaria eradication. London Oxford University Press
11. Bruce-ChwattLJ
1987 Malaria and its control: present situation and future prospects. Ann Rev Public Health 8 75 110
12. NájeraJ
González-SilvaM
AlonsoPL
2011 Some lessons from the previous Global Malaria Eradication Program (1955–1969). PLoS Med 8 e1000412 doi:10.1371/journal.pmed.1000412
13. BockarieMJ
PedersenEM
WhiteGB
MichaelE
2009 Role of vector control in the global program to eliminate lymphatic filariasis. Ann Rev Entomol 54 469 487
14. LengelerC
2004 Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev CD000363
15. HaySI
SnowRW
2006 The malaria Atlas Project: Developing global maps of malaria risk. PLoS Med 3 e473 doi:10.1371/journal.pmed.0030473
16. HaySI
GuerraCA
GethingPW
PatilAP
TatemAJ
2009 A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 6 e1000048 doi:10.1371/journal.pmed.100004
17. HaySI
SinkaME
OkaraRM
KabariaCW
MbithiPM
2010 Developing global maps of the dominant Anopheles vectors of human malaria. PLoS Med 7 e1000209 doi:10.1371/journal.pmed.1000209
18. World Health Organization 2007 Anopheline species complexes in south and south-east Asia. SEARO Technical Publication No. 57 Geneva World Health Organization
19. WondjiCS
IrvingH
MorganJ
LoboNF
CollinsFH
2009 Two duplicated P450 genes are associated with pyrethroid resistance in Anopheles funestus, a major malaria vector. Genome Res 19 452 459
20. YadouletonAW
PadonouG
AsidiA
MoirouxN
Bio-BangannaS
2010 Insecticide resistance status of Anopheles gambiae in southern Benin. Malar J 9 83
21. KleinschmidtI
SchwabeC
ShivaM
SeguraJL
SimaV
2009 Combining indoor residual spraying and insecticide-treated bed net interventions. Am J Trop Med Hyg 81 519 524
22. GuelbeogoWM
SagnonN
GrushkoO
YameogoMA
BoccoliniD
2009 Seasonal distribution of Anopheles funestus chromosomal forms from Burkina Faso. Malar J 8 239 246
23. ThomasMB
ReadAF
2007 Can fungal biopesticides control malaria? Nat Rev Microbiol 5 377 383
24. FarenhorstM
MouatchoJC
KikankieCK
BrookeBD
HuntRH
2009 Fungal infection counters insecticide resistance in African malaria mosquitoes. Proc Natl Acad Sci USA 106 17443 17447
25. PenillaRP
RodriguezAD
HemingwayJ
RarresJL
Arredondo-JimenezJI
1998 Resistance management strategies in malaria vector control. Baseline data for a large-scale field trial against Anopheles albimanus in Mexico. Med Vet Ent 12 217 233
26. KhanZR
MidegaCAO
BruceTJA
HooperAM
PickettJA
2010 Exploiting phytochemicals for developing a “push-pull” crop protection strategy for cereal farmers in Africa. J Exp Botany 6 4185 4196
27. CareyAF
WangG
SuCY
ZwiebelLJ
CarlsonJR
2010 Odorant reception in the mosquito Anopheles gambiae. Nature 464 66 71
28. LawsonD
ArensburgerP
AtkinsonP
BesanskyNJ
BruggnerRV
2009 VectorBase: A data resource for invertebrate vector genomics. Nucleic Acids Res 37 D583 D587
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication
- The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
- Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies